|
Volumn 85, Issue 10 SUPPL., 2000, Pages 52-56
|
Immune tolerance induction: Prospective clinical trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
BLOOD CLOTTING FACTOR 8;
BLOOD CLOTTING FACTOR 8 INHIBITOR;
ANTIBODY TITER;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DOSE RESPONSE;
DRUG EFFICACY;
HEMOPHILIA;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
MORBIDITY;
RANDOMIZED CONTROLLED TRIAL;
ARTICLE;
COST BENEFIT ANALYSIS;
ECONOMICS;
HEMOPHILIA A;
IMMUNOLOGY;
METHODOLOGY;
PROSPECTIVE STUDY;
COST-BENEFIT ANALYSIS;
FACTOR VIII;
HEMOPHILIA A;
HUMANS;
IMMUNE TOLERANCE;
PROSPECTIVE STUDIES;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 0033694687
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (14)
|
References (14)
|